• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Johnson & Johnson (NY: JNJ )

    164.64 -1.51 (-0.91%)
    Streaming Delayed Price Updated: 11:53 AM EDT, Sep 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,393,087
    Open 166.23
    Bid (Size) 164.64 (2)
    Ask (Size) 164.66 (1)
    Prev. Close 166.15
    Today's Range 164.42 - 166.37
    52wk Range 143.13 - 168.85
    Shares Outstanding 2,628,679,824
    Dividend Yield 2.89%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure?
    Pharma stock have been on the rise in the latter half of the year, but the 2024 election remains a wild card for shares. 
    Via Investor's Business Daily
    2 Vanguard Index Funds Could Turn $400 Per Month Into $16,800 in Annual Dividend Income by Retirement
    This two-step strategy could set investors up with a large sum of passive income in retirement. 
    Via The Motley Fool

    Performance

    YTD
    +2.92%
    +2.92%
    1 Month
    +3.14%
    +3.14%
    3 Month
    +11.41%
    +11.41%
    6 Month
    +5.70%
    +5.70%
    1 Year
    +1.51%
    +1.51%

    More News

    Read More
    Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug
    Via Benzinga
    Top 3 Dividend Stocks to Beat Market Volatility and Boost Returns
    Via MarketBeat
    Topics Economy
    Exposures Economy Interest Rates
    Unpacking the Latest Options Trading Trends in Johnson & Johnson
    Via Benzinga
    Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
    Via Benzinga
    Time To Invest And Or Trade In Bio-Tech Stocks?
    Via Talk Markets
    Topics ETFs
    Should You Buy Novavax Stock After This Regulatory Win?
    Via The Motley Fool
    How To Earn $500 A Month From Johnson & Johnson Stock
    Via Benzinga
    Metals in Tampons: FDA Initiates New Safety Measures and Testing
    Via Benzinga
    Exposures Product Safety
    Sony Music-Universal Music JV Hits Johnson & Johnson With Copyright Lawsuit Over Unlicensed Music Use Covering 80 Videos
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    Johnson & Johnson's Mid-Stage Lung Cancer Trial Reveals Fewer Infusion-Related Reactions
    Via Benzinga
    3 Safe Stocks with Safe Dividends for Your Portfolio
    Via MarketBeat
    Topics Economy
    Exposures Economy
    Is Hims & Hers Health the Next Teladoc?
    Via The Motley Fool
    Exposures COVID-19
    2 Stocks That Are Passive Income Machines to Buy and Hold Forever
    Via The Motley Fool
    Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
    Via Benzinga
    Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
    Via Benzinga
    Dell, CoStar, PayPal And A Major Health Care Stock On CNBC's 'Final Trades'
    Via Benzinga
    Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
    Via Benzinga
    Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
    From Johnson & Johnson
    Via Business Wire
    Johnson & Johnson Raises Talc Settlement Offer to $9B, Moves Closer to Settlement Victory
    Via Benzinga
    Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    2 Dividend Stocks With Payouts That May Not Be as Safe as They Seem
    Via The Motley Fool
    Court Orders Johnson & Johnson To Compensate Auris Health Shareholders $1B
    Via Benzinga
    3 Dividend Stocks to Double Up on Right Now
    Via The Motley Fool
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.